Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Prostavasin Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Prostavasin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 890,399Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 EUROAPI
    France
    		 Samoh Pharmaceutical Co., Ltd. 20230202-210-J-1440 Alprostadil 2023-02-02 EUROAPI Hungary Ltd. Hungary To utca 1-5., Budapest, 1045, Hungary
    28/09/2024 Yonsung Fine Chemicals
    South Korea
    		 YS Life Science Co., Ltd. 20240206-210-J-1611 Alprostadil 2024-02-06 YS Life Science Co., Ltd. South Korea 207 Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do